Empirically, EGCG inhibits in situ tumor growth, angiogenesis, and metastasis in PC, which is associated with PI3K/AKT and ERK pathway suppression coupled with FKHRL1/FOXO3a activation (22). Here, FOXO3 is linked to neoplasm.